The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Nuclear Medicine Equipment Market Over The Period 2026–2030?
The nuclear medicine equipment market has seen robust expansion in recent years. It is anticipated to expand from $2.81 billion in 2025 to $2.97 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.7%. The growth observed historically is attributable to an increase in the aging population, rising cancer prevalence, enhanced adoption of diagnostic imaging, improvements in hospital infrastructure, and government funding directed towards nuclear medicine.
The nuclear medicine equipment market is anticipated to experience robust expansion over the coming years, with projections indicating a rise to $3.67 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.4%. This growth throughout the forecast period is primarily due to increased adoption of theranostics, a heightened demand for precision medicine, technological progress in hybrid imaging, the escalating burden of cardiovascular diseases, and the proliferation of imaging centers in emerging markets. Significant trends expected during this period include the development of advanced hybrid imaging systems, an expansion of theranostics applications, a growing embrace of personalized nuclear diagnostics, an intensified focus on radiation dose optimization, and an increasing need for outpatient nuclear imaging services.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20582&type=smp
Which Major Factors Are Driving The Expansion Of The Nuclear Medicine Equipment Market?
The growing occurrence of heart conditions is projected to drive the expansion of the nuclear medicine equipment market. Heart ailments, also known as cardiovascular diseases, encompass a wide array of conditions impacting the heart and blood vessels, potentially affecting heart function, its structure, or the circulation of blood. Their increased prevalence stems largely from an aging global population, lifestyle factors like unhealthy diets and physical inactivity, environmental influences, and improved diagnostic methods that enhance detection. Nuclear medicine equipment plays a crucial role in managing these conditions by offering precise imaging and diagnostic insights, facilitating early diagnosis, accurate disease staging, and efficient ongoing monitoring. For example, data released in January 2024 by the British Heart Foundation, a UK-based cardiovascular research charity, indicates that in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, comprising around 4 million males and 3.6 million females. These conditions account for about 27% of all deaths in the UK, amounting to over 170,000 deaths annually, or roughly 480 deaths each day, which is equivalent to one death every three minutes. Consequently, the rising occurrence of cardiac ailments significantly propels the expansion of the nuclear medicine equipment market.
How Is The Nuclear Medicine Equipment Market Divided Into Its Major Segments?
The nuclear medicine equipment market covered in this report is segmented –
1) By Product: Single Photon Emission Computed Tomography, Hybrid Positron Emission Tomography, Planar Scintigraphy
2) By Application: Oncology, Cardiology, Neurology, Other Applications
3) By End User: Hospitals, Imaging Centers, Academic And Research Institutes, Other End Users
Subsegments:
1) By Single Photon Emission Computed Tomography: Standalone SPECT Systems, Hybrid SPECT Or CT Systems
2) By Hybrid Positron Emission Tomography: PET Or CT Systems, PET Or MRI Systems
3) By Planar Scintigraphy: Cardiac Imaging Systems, Bone Scintigraphy Systems, Thyroid Imaging Systems
How Are Trends Transforming The Nuclear Medicine Equipment Market Landscape?
Leading companies in the nuclear medicine equipment market are concentrating on developing sophisticated products, such as PET/CT scanners, to deliver highly detailed, functional images of the body’s metabolic processes. A PET/CT scanner is an advanced imaging device utilized in nuclear medicine that integrates two technologies: positron emission tomography (PET) and computed tomography (CT). This dual-modality scanner offers both functional and anatomical imaging in a single session, enabling doctors to more accurately detect and diagnose various conditions. For example, in June 2024, Siemens Healthineers, a Germany-based healthcare company, introduced the Biograph Trinion PET/CT scanner. The PET scanner features a unique, scalable axial field-of-view design, allowing for on-site technological upgrades without requiring costly room renovations or disrupting workflow. It incorporates a lutetium oxyorthosilicate (LSO) crystal detector, which provides high spatial resolution and an ultrafast time-of-flight performance of 239 picoseconds, enhancing the detectability of small lesions and offering adequate sensitivity up to 128 cps/kBq. This innovation facilitates rapid scans with reduced patient radiation doses. Additionally, the Biograph Trinion includes a new air-cooled digital detector, simplifying installation compared to traditional water-cooled systems.
Who Are The Prominent Organizations Shaping The Nuclear Medicine Equipment Market?
Major companies operating in the nuclear medicine equipment market are Fujifilm Holdings Corporation, Koninklijke Philips N.V., General Electric Company, Shimadzu Corporation, Mallinckrodt Pharmaceuticals, Curium Pharma, Cardinal Health Inc., Canon Medical Systems Corporation, Digirad Corporation, TTG Imaging Solutions, Biodex Medical Systems Inc., Spectrum Dynamics Medical, Mediso Ltd., Cyclopharm Limited, Siemens Healthineers AG, Capintec Inc., Toshiba Medical Systems Corporation, Elysia-Raytest, DDD-Diagnostic A/S, MILabs B.V.
Read the full nuclear medicine equipment market report here:
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-equipment-global-market-report
Which Region Currently Holds The Largest Share Of The Nuclear Medicine Equipment Market?
North America was the largest region in the nuclear medicine equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Nuclear Medicine Equipment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20582&type=smp
Browse Through More Reports Similar to the Global Nuclear Medicine Equipment Market 2026, By The Business Research Company
Nuclear Medicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report
Nuclear Decommissioning Services Market Report 2026
Nuclear Fusion Market Report 2026
https://www.thebusinessresearchcompany.com/report/nuclear-fusion-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model